ACOR
Marshall Wace’s Acorda Therapeutics, Inc. ACOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-143,297
| Closed | -$293K | – | 2125 |
|
|
2019
Q4 | $293K | Sell |
143,297
-115,088
| -45% | -$235K | ﹤0.01% | 1236 |
|
|
2019
Q3 | $741K | Sell |
258,385
-183,623
| -42% | -$527K | 0.01% | 969 |
|
|
2019
Q2 | $3.39M | Sell |
442,008
-141,742
| -24% | -$1.09M | 0.03% | 590 |
|
|
2019
Q1 | $7.76M | Buy |
583,750
+185,061
| +46% | +$2.46M | 0.07% | 324 |
|
|
2018
Q4 | $6.21M | Buy |
+398,689
| New | +$6.21M | 0.06% | 385 |
|
|
2016
Q3 | – | Sell |
-35,931
| Closed | -$916K | – | 1174 |
|
|
2016
Q2 | $916K | Buy |
35,931
+21,478
| +149% | +$548K | 0.01% | 717 |
|
|
2016
Q1 | $382K | Buy |
+14,453
| New | +$382K | ﹤0.01% | 892 |
|
|
2014
Q4 | – | Sell |
-145,030
| Closed | -$4.91M | – | 1023 |
|
|
2014
Q3 | $4.91M | Buy |
+145,030
| New | +$4.91M | 0.07% | 291 |
|